Step 1 topics → Neurology and Special Senses → Neural Tube Defects

Neural Tube Defects

USMLE Step 1 trap: Treats elevated maternal AFP as specific to neural tube defects, ignoring other causes. Elevated maternal serum AFP occurs in open NTDs but also in ventral wall defects (gastroschisis, omphalocele), multiple gestations, and incorrect dating.

Neural tube defects (NTDs) result from failed closure of the neural tube during weeks 3-4 of embryogenesis. The defects range from lethal (anencephaly) to asymptomatic (spina bifida occulta), and the USMLE Step 1 tests this spectrum repeatedly — both as direct recall and as clinical vignette interpretation. You need to know which end of the tube failed, what structures are exposed, and how prenatal screening catches these defects before birth.

The exam hits this topic from three main angles: spectrum knowledge (match the defect to the neuropore and clinical presentation), prenatal screening interpretation (what AFP levels and ultrasound findings mean and when they're falsely abnormal), and the folate-prevention mechanism (why folate works, why antiepileptics are dangerous, and when supplementation must start). The prevention angle is particularly high-yield because it requires mechanistic thinking, not just memorization.

The two classic traps on USMLE Step 1: students flip anterior and posterior neuropore assignments (putting anencephaly at the wrong end), and students treat elevated maternal AFP as diagnostic of NTDs specifically — missing that gastroschisis, omphalocele, and even incorrect gestational dating can all push AFP up. These are the exact scenarios that show up in answer choices designed to catch you.

From real student decks
73%have cards covering this topic
65%have mature cards

Common misconceptions

Common mistake
Wrong: Elevated maternal serum AFP is specific to open neural tube defects and cannot be elevated in other conditions.
Right: Elevated maternal serum AFP occurs in open NTDs but also in ventral wall defects (gastroschisis, omphalocele), multiple gestations, and incorrect dating.
Elevated maternal serum AFP is a marker of fetal tissue leaking into maternal circulation — it is NOT specific to NTDs. Any open ventral wall defect like gastroschisis or omphalocele causes the same elevation, as do multiple gestations and incorrect gestational dating (AFP is age-normalized, so a miscalculated due date can make a normal value look elevated). When you see elevated AFP on the exam, your job is to consider the full differential and look for confirmatory findings before calling it an NTD.
Common mistake
Wrong: Anencephaly results from failure of posterior neuropore closure.
Right: Anencephaly results from failure of anterior neuropore closure, while spina bifida results from failure of posterior neuropore closure.
The neural tube closes from the middle outward, with the anterior neuropore closing around day 25 and the posterior neuropore closing around day 27. Anencephaly — failure to develop the forebrain and calvarium — is an anterior neuropore defect because the anterior end never closes. Spina bifida, which involves the spinal cord and lumbar vertebrae, is a posterior neuropore defect. A good anchor: 'anterior = above, affects the brain; posterior = below, affects the spine.'
Common mistake
Wrong: Folate prevents NTDs by directly inhibiting neural tube closure defects through an unknown mechanism unrelated to DNA synthesis.
Right: Folate is required for nucleotide synthesis via the one-carbon cycle; deficiency impairs rapidly dividing neural tube cells, and supplementation before conception reduces NTD risk.
Folate is not some vague 'neural tube stabilizer' — it is an essential cofactor in one-carbon metabolism, which generates the building blocks (purines, thymidine) needed for DNA synthesis and cell division. Rapidly dividing neural tube cells during weeks 3-4 are exquisitely sensitive to nucleotide shortage. When folate is insufficient, cell division in the closing neural tube stalls or fails. This is why supplementation needs to start at least one month before conception — the tube is already closed by the time most women know they're pregnant.
Common mistake
Gap: Unaware that valproate causes NTDs by impairing folate metabolism
Valproate inhibits folate metabolism and is a potent NTD teratogen, particularly causing spina bifida, making folate supplementation especially important in women of childbearing age on antiepileptics.
Valproate is one of the most potent teratogenic antiepileptics, and its mechanism ties directly back to folate. Valproate inhibits folate metabolism, creating a functional folate deficiency in the developing embryo and dramatically increasing the risk of spina bifida (posterior neuropore defect) — the risk is roughly 1-2%, compared to a background rate of ~0.1%. This is why any woman of childbearing age on valproate (or other folate-antagonist antiepileptics like carbamazepine) should be on folic acid supplementation, and ideally switched to a safer agent before attempting conception.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the full spectrum of NTDs — from spina bifida occulta (bony defect only, skin intact, asymptomatic) through meningocele (meninges herniate) and myelomeningocele (meninges + spinal cord herniate, most clinically severe) to anencephaly — and be able to match each to its embryologic origin and clinical consequences.
  2. Interpret prenatal screening results for NTDs: understand that open NTDs (myelomeningocele, anencephaly) cause elevated maternal serum AFP and low acetylcholinesterase in amniotic fluid, that ultrasound findings like the lemon and banana signs point to associated Chiari II malformation, and critically — that elevated AFP is not specific to NTDs.
  3. Explain mechanistically why folate prevents NTDs: folate drives one-carbon metabolism for nucleotide synthesis, rapidly dividing neural tube cells are especially vulnerable to folate deficiency, and supplementation must begin before conception (not after a missed period) to be effective. Also know that valproate and other antiepileptics impair folate metabolism and dramatically increase NTD risk.

Can you avoid these mistakes?

A 26-year-old woman at 16 weeks gestation has a maternal serum AFP of 3.2 MoM (elevated). Ultrasound shows a normal-appearing fetus with no structural defects. What are three causes of elevated AFP you need to rule out before concluding this is a neural tube defect?
A newborn has a fluid-filled sac at the lumbosacral level. On exam, the sac is covered with skin and the infant has normal lower extremity motor function and normal bladder control. What is the diagnosis, which neuropore failed, and how does this differ from myelomeningocele?
A woman with epilepsy is taking valproate and wants to become pregnant. Her neurologist wants to start folic acid. Explain the mechanism by which valproate increases NTD risk and why folate supplementation must begin before conception rather than at the first prenatal visit.
Prenatal screening returns results for three fetuses: Fetus A has anencephaly, Fetus B has myelomeningocele, Fetus C has spina bifida occulta. For each fetus, identify which neuropore failed and on what gestational day, and predict whether maternal serum AFP would be elevated or normal — and why.

Related topics

Neural Tube Formation and Derivatives Neural Crest Derivatives Other Developmental Malformations Cerebral Cortex — Lobes and Functional Areas

See how your Anki deck covers this topic.

Upload your deck for a free audit →